Document:

Termination Agreement - Medical Futures, Inc.

 Exhibit 10.98 
 TERMINATION AGREEMENT 
 THIS
AGREEMENT for the termination (“Termination Agreement”) of certain agreements by and between Anesiva, Inc., a Delaware corporation, having a principal place of business at 400 Oyster Point Boulevard, Suite 502, South San
Francisco, California 94080 (“Anesiva”), and Medical Futures, Inc., an Ontario corporation, having a principal place of business at 16 Sims Crescent, Richmond Hill, ON L4B 2P1, Canada (“MFI”) dated November 17, 2007 is made
and entered into as of the 20th day of October, 2009 (the “Effective Date”). Anesiva and MFI may be referred to individually herein as a “Party” and collectively as the “Parties.” 
 WHEREAS, Anesiva and MFI are parties to a License and Distribution Agreement dated November 17, 2007 (“the License
Agreement”); and 
 WHEREAS, Anesiva and MFI wish to terminate the License Agreement as mutually agreed upon and
detailed herein. 
 NOW, THEREFORE, the Parties in consideration of the mutual undertakings and covenants
contained herein and parties hereto, intending to be legally bound and for good and valid consideration, hereby agree as follows: 
  

	 	1.	The License Agreement is hereby terminated as of the Effective Date. 

  

	 	2.	Within fifteen (15) days after the closing of the merger by and between Anesiva, Inc. and Arcion Therapeutics, Anesiva shall pay MFI the sum of Forty Five Thousand
United States Dollars (US $45,000). 

  

	 	3.	Within thirty (30) days of the Effective Date, MFI will be responsible for terminating any agreements entered into with Affiliates or other parties pursuant to the
License Agreement. 

  

	 	4.	Upon the Effective Date, each Party will immediately release and discharge the other Party, and all of its Affiliates, from any and all of its obligations and
responsibilities, whether known or unknown, under the License Agreement. 

  

	 	5.	Any and all confidential and/or proprietary information disclosed pursuant to the License Agreement and covered by the Confidential Disclosure Agreement entered into by
the Parties on August 27, 2007 and made, by reference, part of the License Agreement shall be extended for a term of five (5) years following the Effective Date of this Termination Agreement. 

  

	 	6.	The Parties agree that this Termination Agreement shall be governed by and construed in accordance with the laws of the State of California. 

 

			
	MFI TERMINATION AGREEMENT	  	PAGE 1 OF 2

	 	7.	Each Party represents and warrants that it is fully authorized to enter into this Termination Agreement and to carry out the obligations provided for herein.

  

	 	8.	This Termination Agreement may be executed in two or more counterparts, each of which shall constitute an original, but all of which, when taken together, shall
constitute a single instrument. 

  

	 	9.	This Termination Agreement constitutes the entire agreement of the parties concerning the subject matter hereof, superseding all prior and contemporaneous proposals,
negotiations, communications and agreements, written or oral, with respect to the subject matter of this Termination Agreement. 

 IN WITNESS WHEREOF, the Parties, have authorized and executed this Termination Agreement the date and year first written above. 
  

			
	Executed by	    	Executed by
	MEDICAL FUTURES, INC.	    	ANESIVA, INC.
	16 Sims Crescent, Suite 29	    	400 Oyster Point Boulevard, Suite 502
	Richmond Hill	    	South San Francisco, CA 94080
	ON l4B 2P1	    	
	Canada	    	
		
	 /s/ Par Nijhawan, MD
	    	 /s/ John H. Tran

		
	 Name: Par Nijhawan, MD
	    	 Name: John H. Tran

	Title:   Medical Director,	    	 Title:   VP, Finance & Chief Accounting

	            New Business Development	    	

  

			
	MFI TERMINATION AGREEMENT	  	PAGE 2 OF 2Termination Agreement - Green Vision Company

 Exhibit 10.99 
 TERMINATION AGREEMENT 
 THIS AGREEMENT for the termination (“Termination Agreement”) of certain agreements by and between Anesiva, Inc., a Delaware corporation, having a principal place of business at 400 Oyster Point
Boulevard, Suite 502, South San Francisco, California 94080 (“Anesiva”), and Green Vision Company with a principal place of business at Al Azizya, Doha, Qatar (“GVC”) dated April 16, 2008 is made and entered into as of the
10th day of November, 2009 (the “Effective
Date”). Anesiva and GVC may be referred to individually herein as a “Party” and collectively as the “Parties.” 
 WHEREAS, Anesiva and GVC are parties to a License and Distribution Agreement dated April 16, 2008 (“the License Agreement”); and 
 WHEREAS, Anesiva and GVC wish to terminate the License Agreement as mutually agreed upon and detailed herein. 
 NOW, THEREFORE, the Parties in consideration of the mutual undertakings and covenants contained herein and parties hereto, intending
to be legally bound and for good and valid consideration, hereby agree as follows: 
  

	 	1.	The License Agreement is hereby terminated as of the Effective Date. 

  

	 	2.	Within fifteen (15) days after the closing of the merger by and between Anesiva, Inc. and Arcion Therapeutics, and no later than December 30th, 2009 in all
circumstances, Anesiva shall pay GVC the sum of Twenty Five Thousand Dollars ($25,000) in United States dollar by bank transfer to GVC’s bank account in Qatar. 

  

	 	3.	Within thirty (30) days of the Effective Date, GVC will be responsible for terminating any agreements entered into with Affiliates or other parties pursuant to the
License Agreement. 

  

	 	4.	Upon the Effective Date, each Party will immediately release and discharge the other Party, and all of its Affiliates, from any and all of its obligations and
responsibilities, whether known or unknown, under the License Agreement. 

  

	 	5.	Any and all confidential and/or proprietary information disclosed pursuant to the License Agreement and covered by the Confidential Disclosure Agreement entered into by
the Parties on January8, 2008 and made, by reference, part of the License Agreement shall be extended for a term of five (5) years following the Effective Date of this Termination Agreement. 

  

			
	GVC TERMINATION AGREEMENT	  	PAGE 1 OF 2

	 	6.	The Parties agree that this Termination Agreement shall be governed by and construed in accordance with the laws of the State of California. 

 

	 	7.	Each Party represents and warrants that it is fully authorized to enter into this Termination Agreement and to carry out the obligations provided for herein.

  

	 	8.	This Termination Agreement may be executed in two or more counterparts, each of which shall constitute an original, but all of which, when taken together, shall
constitute a single instrument. 

  

	 	9.	This Termination Agreement constitutes the entire agreement of the parties concerning the subject matter hereof, superseding all prior and contemporaneous proposals,
negotiations, communications and agreements, written or oral, with respect to the subject matter of this Termination Agreement. 

 IN WITNESS WHEREOF, the Parties, have authorized and executed this Termination Agreement the date and year first written above. 
  

			
	Executed by	    	Executed by
	GREEN VISION COMPANY	    	ANESIVA, INC.
	P.O. Box 55272	    	400 Oyster Point Boulevard, Suite 502
	Doha, Qatar	    	South San Francisco, CA 94080
		
	 /s/ Amjad Abdullah
	    	 /s/ John H. Tran

		
	 Name: Amjad Abdullah
	    	 Name: John H. Tran

	Title:   Managing Partner	    	 Title:   VP, Finance & Chief Accounting

	            Managing Partner, Sales & Operation	    	

  

			
	GVC TERMINATION AGREEMENT	  	PAGE 2 OF 2Promissory Note

 Exhibit 10.1 
 Promissory Note 
 On this date of June 1, 2009, in return for valuable consideration received, the
undersigned borrower promises to pay to Seatac Digital Resources, Inc., the “Lender”, the sum of One-Hundred Thousand Dollars ($100,000.00), together with interest thereon at the rate of five percent (5%) percent per annum.

 Payable On Demand: The entire unpaid principal and accrued interest thereon, if any, shall become immediately due and payable on demand by the
holder of this Note. 
 Default - In the event of default, the borrower agrees to pay all costs and expenses incurred by the Lender, including all
reasonable attorney fees (including both hourly and contingent attorney fees as permitted by law) for the collection of this Note upon default, and including reasonable collection charges (including, where consistent with industry practices, a
collection charge set as a percentage of the outstanding balance of this Note) should collection be referred to a collection agency. 
 Acceleration of
Debt - In the event that the borrower fails to make any payment due under the terms of this Note, or breach any condition relating to any security, security agreement, note, mortgage or lien granted as collateral security for this Note, seeks
relief under the Bankruptcy Code, or suffers an involuntary petition in bankruptcy or receivership not vacated within thirty (30) days, the entire balance of this Note and any interest accrued thereon shall be immediately due and payable to the
holder of this Note. 
 Modification - No modification or waiver of any of the terms of this Agreement shall be allowed unless by written agreement
signed by both parties. No waiver of any breach or default hereunder shall be deemed a waiver of any subsequent breach or default of the same or similar nature. 
 Transfer of the Note - The borrowers hereby waive any notice of the transfer of this Note by the Lender or by any subsequent holder of this Note, agree to remain bound by the terms of this Note subsequent to any transfer, and agree
that the terms of this Note may be fully enforced by any subsequent holder of this Note. 
 Severability of Provisions - In the event that any
portion of this Note is deemed unenforceable, all other provisions of this Note shall remain in full force and effect. 
 Choice of Law - All terms
and conditions of this Note shall be interpreted under the laws of The State of California. 
 Dated: June 1, 2009 
  

	
	 /s/ Donald R. Mastropietro

	 America’s Minority Health Network, Inc.
 Borrower

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00165-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00165-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00165-of-00352.parquet"}]]